Get the Stockscreener App
0.011
50.45%
-0.0112
T 2 Biosystems Inc stock is traded at $0.011, with a volume of 13,876.
It is down -50.45% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$0.0222
Open:
$0.012
24h Volume:
13,876
Relative Volume:
1.58
Market Cap:
$N/A
Revenue:
$7.68M
Net Income/Loss:
$-42.95M
P/E Ratio:
-0.000482
EPS:
-22.8421
Net Cash Flow:
$-36.62M
1W Performance:
-50.45%
1M Performance:
+0.00%
6M Performance:
-93.36%
1Y Performance:
-95.82%
1-Day Range:
$0.0025
$0.012
1-Week Range:
$0.0025
$0.012
52-Week Range:
$0.0025
$0.165
T 2 Biosystems Inc Stock (TTOO) Company Profile
Name
T 2 Biosystems Inc
Sector
Industry
Phone
-
Address
-
Compare TTOO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.011 | 0 | 7.68M | -42.95M | -36.62M | -22.84 |
|
TMO
Thermo Fisher Scientific Inc
|
538.92 | 202.69B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
209.06 | 151.03B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.40 | 50.99B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.92 | 40.00B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.55 | 34.98B | 15.70B | 1.24B | 2.01B | 6.9036 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Nov-26-19 | Downgrade | Janney | Buy → Neutral |
| Aug-01-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jul-31-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-31-19 | Downgrade | Janney | Buy → Neutral |
| May-16-19 | Initiated | Alliance Global Partners | Buy |
| Mar-08-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-01-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| May-30-18 | Reiterated | H.C. Wainwright | Buy |
| May-29-18 | Reiterated | WBB Securities | Strong Buy |
| Mar-29-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Goldman | Neutral |
| Oct-18-17 | Initiated | H.C. Wainwright | Buy |
| Mar-15-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-10-16 | Resumed | Leerink Partners | Mkt Perform |
| Nov-02-16 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-20-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Jun-22-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Apr-12-16 | Reiterated | Canaccord Genuity | Buy |
| Feb-17-16 | Initiated | WBB Securities | Speculative Buy |
View All
T 2 Biosystems Inc Stock (TTOO) Latest News
Why retail investors favor Rapid Micro Biosystems Inc. stock2025 Trading Volume Trends & Low Risk Entry Point Tips - nchmf.gov.vn
TTOO Interactive Stock Chart | T2 Biosystems, Inc. Stock - Yahoo Finance
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
GBS (NYSE:GBS) versus T2 Biosystems (NASDAQ:TTOO) Head-To-Head Survey - Defense World
Reviewing T2 Biosystems (NASDAQ:TTOO) & Titan Medical (NASDAQ:TMDIF) - Defense World
EBIT per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway - Investing News Network
Lyme Disease Pipeline 2025: In-Depth Clinical Trials Analysis And Emerging Therapies Report By Delveinsight Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Menafn.com
Reviewing Titan Medical (NASDAQ:TMDIF) and T2 Biosystems (NASDAQ:TTOO) - Defense World
Sepsis Diagnostics Market Poised for Remarkable Expansion by 2035, Reveals Prophecy Market Insights Study - newstrail.com
Will Retractable Technologies Inc. outperform the marketJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
T2 Biosystems, Inc. (NASDAQ:TTOO) Sees Significant Drop in Short Interest - Defense World
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates - MSN
Rapid Micro Biosystems Reports 15% Recurring Revenue Growth, Lands Major $45M Financing Deal - Stock Titan
Apyx Medical Strengthens Global Sales Leadership with Strategic Hires as New AYON System Launches - Stock Titan
Short Interest in T2 Biosystems, Inc. (NASDAQ:TTOO) Expands By 1,146.7% - Defense World
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells - Nature
Rapid Micro: Lake Street initiates coverage with Buy rating, PT $8. - AInvest
T2 Biosystems (NASDAQ:TTOO) versus InspireMD (NYSE:NSPR) Financial Review - Defense World
What analysts say about Rapid Micro Biosystems Inc. stockUnmatched profit potential - Autocar Professional
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Does Rapid Micro Biosystems Inc. stock pay reliable dividends200 Percent Profit Outlook - beatles.ru
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming Earnings Reports and Analyst Ratings Actions - AInvest
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Investor Network: T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above 50-Day Moving Average – Should You Sell? - Defense World
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Wall Street Zen Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200 Day Moving Average – Should You Sell? - Defense World
StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - The AM Reporter
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200-Day Moving Average – Time to Sell? - The AM Reporter
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - simplywall.st
Microbix Biosystems Leads These 3 TSX Penny Stocks To Watch - simplywall.st
Rapid Micro Biosystems, Inc. (RPID): Among the Hot Penny Stocks to Buy Now - Yahoo Finance
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Balance Sheet – OTC:TTOO - TradingView
T 2 Biosystems Inc Stock (TTOO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
1.44%
Cap:
|
Volume (24h):